Clinical Trials Insight: 700043674

Trial Profile

Clinical Trials Insight: 700043674

Phase of Trial: Phase I

Latest Information Update: 11 Jan 2010

At a glance

  • Drugs ApoB SNALP (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Sponsors Tekmira Pharmaceuticals Corporation
  • Most Recent Events

    • 11 Jan 2010 Status changed to completed, based on information from a Temkira media release.
    • 02 Jul 2009 Status changed from not yet recruiting to recruiting as reported by Tekmira Pharmaceuticals.
    • 07 May 2009 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top